PubMed HealthSearch

PubMed · 2829605

Tuberculin sensitivity in tuberculosis.

Abstract

Seven of twenty-eight (25%) patients with untreated tuberculosis had skin induration of less than 6 mm to one tuberculin unit (TU), and 3 (11%) to 10 TU PPD. Among twenty-four patients with lung disease, there were no detectable differences in radiological extent of disease between reactors and non-reactors to low-dose tuberculin. However, non-reactors were significantly more malnourished (P less than 0.02), excreted more bacilli (P less than 0.02) and took longer for sputum sterilization during chemotherapy (P less than 0.01). Early skin reactions (6-8 h) occurred in fourteen of twenty-four (58%) patients, but in none of twenty-four matched healthy controls (P less than 0.0001); the proportions giving delayed (48-72 h) reactions were similar. Although the patients had larger delayed reactions as a group (P = 0.04), this would not have been of value in making the diagnosis. Repeat tuberculin testing of subjects had a booster effect, but did not induce hypersensitivity in initially healthy non-reactors. All nutritional abnoalities observed in the patients, except arm muscle circumference and serum albumin, reverted to normal during chemotherapy, concomitant with clinical improvement and an increase in dermal reactivity to tuberculin. Antigen overload may lead to both skin anergy and undernutrition. The accelerated tuberculin skin reaction could offer a practical and specific, although not particularly sensitive, method of aiding the diagnosis of active tuberculosis.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J K Onwubalili. 1987. Tuberculin sensitivity in tuberculosis.. https://pubmed.ncbi.nlm.nih.gov/2829605/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Drug-resistant tuberculosis: review of the worldwide situation and the WHO/IUATLD Global Surveillance Project. International Union Against Tuberculosis and Lung Disease.

The emergence of strains of Mycobacterium tuberculosis that are resistant to antimycobacterial agents is a worldwide problem whose global magnitude is not well described. We reviewed and tabulated 63 surveys of resistance to antituberculous drugs that were performed between 1985 and 1994. Rates of primary resistance to isoniazid, administered as a single agent, ranged from 0 to 16.9% (median rate, 4.1%); to streptomycin, 0.1%-23.5% (median, 3.5%); to rifampin, 0-3.0% (median, 0.2%); and to ethambutol, 0-4.2% (median, 0.1%). The rates of acquired resistance to these agents, which were higher than those of primary resistance, were as follows: isoniazid, 4.0%-53.7% (median rate, 10.6%); streptomycin, 0-19.4% (median, 4.9%); rifampin 0-14.5% (median, 2.4%); and ethambutol, 0-13.7% (median, 1.8%). The highest rates of multidrug-resistant tuberculosis have been reported in Nepal (48.0%), Gujarat, India (33.8%), New York City, (30.1%), Bolivia (15.3%), and Korea (14.5%). The WHO (World Health Organization) and the IUATLD (International Union Against Tuberculosis and Lung Disease) have established a global project of drug resistance surveillance that is based on standard epidemiological methods and quality control through an extensive network of reference laboratories. Accurate drug resistance surveillance data can be used to assess and improve national tuberculosis programs.

Antitubercular Agents